Literature DB >> 11404206

Managing adolescent acne.

D P Krowchuk1, A W Lucky.   

Abstract

Acne vulgaris, more commonly termed acne, is the most common skin disease treated by physicians. It affects an estimated 17 million people in the United States, including 85% or more of adolescents and young adults. Acne is a chronic condition that may last for years and cause emotional distress and permanent scarring. Although there is no cure, medications can control the disease and limit or prevent scar formation.

Entities:  

Mesh:

Year:  2001        PMID: 11404206

Source DB:  PubMed          Journal:  Adolesc Med        ISSN: 1041-3499


  2 in total

1.  Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile.

Authors:  E Zulian; P Sartorato; S Benedini; G Baro; D Armanini; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

2.  Efficacy of Spironolactone in Adult Acne in Polycystic Ovary Syndrome Patients an Original Research.

Authors:  Neha Rani; Prashant Kumar; Anup Kumar Mishra; Bala Yadu Vamsi Sankuratri; Sanjana Sethi; Kalyani Gelada; Heena Tiwari
Journal:  J Pharm Bioallied Sci       Date:  2021-11-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.